0001144204-18-044623.txt : 20180814
0001144204-18-044623.hdr.sgml : 20180814
20180814160216
ACCESSION NUMBER: 0001144204-18-044623
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180630
FILED AS OF DATE: 20180814
DATE AS OF CHANGE: 20180814
EFFECTIVENESS DATE: 20180814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management II, LLC
CENTRAL INDEX KEY: 0001594912
IRS NUMBER: 464028844
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16497
FILM NUMBER: 181017213
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001594912
XXXXXXXX
06-30-2018
06-30-2018
false
Foresite Capital Management II, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-16497
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
08-14-2018
0
10
283859
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
11876
244756
SH
SOLE
244756
0
0
Adaptimmune Therapeutics PLC
SPONDS ADR
00653A107
8309
700000
SH
SOLE
700000
0
0
Aerie Pharmaceuticals, Inc.
COM
00771V108
98944
1464749
SH
SOLE
1464749
0
0
Aimmune Therapeutics, Inc.
COM
00900T107
90263
3356749
SH
SOLE
3356749
0
0
Alder BioPharmaceuticals, Inc.
COM
014339105
26642
1686220
SH
SOLE
1686220
0
0
BioDelivery Sciences International, Inc.
COM
09060J106
90
30500
SH
SOLE
30500
0
0
Denali Therapeutics Inc.
COM
24823R105
3813
250000
SH
SOLE
250000
0
0
Epizyme, Inc.
COM
29428V104
19894
1468215
SH
SOLE
1468215
0
0
Insmed Incorporated
COM
457669307
22885
967636
SH
SOLE
967636
0
0
Sangamo Therapeutics, Inc.
COM
800677106
1143
80500
SH
SOLE
80500
0
0